NeuroBo Pharmaceuticals, Inc. logo

NeuroBo Pharmaceuticals, Inc.


Overview | Financials
Company Name NeuroBo Pharmaceuticals, Inc.
Symbol NRBO
Currency USD
Price 5
Market Cap 28,346,800
Dividend Yield 0%
52-week-range 2.9 - 6.75
Industry Biotechnology
Sector Healthcare
CEO Mr. Hyung-Heon Kim

An error occurred while fetching data.

About NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat

Related Stocks

Cyclacel Pharmaceuticals, Inc. logo

Cyclacel Pharmaceuticals, Inc.


11.81 USD

Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc.


0.495 USD


Numbers are in millions USD

Numbers are in millions USD